Get started
Author

Glenn F. van Wigcheren

Observed names: G. F. van Wigcheren, Glenn F. Van Wigcheren, Glenn van Wigcheren, Wigcheren, G.F. van
Observed institutions: Radboud University Nijmegen, Radboud University Medical Center, University Medical Center Utrecht, Radboud Institute for Molecular Life Sciences, Oncode Institute, Byondis BV (Netherlands)
ORCID: 0000-0001-7787-0002
Observed ORCID: 0000-0001-7787-0002
OpenAlex ID: A5084868705
The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture
2020 · S. Di Blasio, G. F. van Wigcheren, et al. · Nature Communications · 102
PDF
LukMF′ is the major secreted leukocidin of bovine Staphylococcus aureus and is produced in vivo during bovine mastitis
2016 · Manouk Vrieling, Eveline M. Boerhout, et al. · Scientific Reports · 88
PDF
Identification of LukPQ, a novel, equid-adapted leukocidin of Staphylococcus aureus
2017 · Gerrit Koop, Manouk Vrieling, et al. · Scientific Reports · 74
PDF
Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients
2021 · Glenn F. Van Wigcheren, Nienke De Haas, et al. · OncoImmunology · 37
PDF
Myeloid-derived suppressor cells and tolerogenic dendritic cells are distinctively induced by PI3K and Wnt signaling pathways
2023 · Glenn F. van Wigcheren, Jorge Cuenca-Escalona, et al. · Journal of Biological Chemistry · 20
PDF
Three distinct tolerogenic CD14+ myeloid cell types to actively manage autoimmune disease: Opportunities and challenges
2021 · Glenn F. van Wigcheren, Daphne Roelofs, et al. · Journal of Autoimmunity · 5
PDF
Potent in Vitro and In Vivo Efficacy of BYON4413, a Duba-Based Antibody-Drug Conjugate Targeting CD123 in Acute Myeloid Leukemia
2023 · Miranda van der Lee, Tanja van Achtenberg, et al. · Blood · 3
Abstract 3129: BYON4413, an in vivo active CD123-targeting antibody-drug conjugate, combines effectively with azacitidine and venetoclax in acute myeloid leukemia cell lines
2024 · Miranda M.C. van der Lee, Tanja van Achterberg, et al. · Cancer Research · 1
Works count: 9
Citation count: 330
H-index: 5
I10-index: 5
Year
Topic
Type